Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4269676 | 0.91 | TSHR (0.38) | TSHR | |
| SCHEMBL231687 | 0.84 | — | — | |
| SCHEMBL2364207 | 0.83 | TSHR (0.41) | TSHR | |
| SCHEMBL4271659 | 0.81 | OPRM1 (0.44) | TSHR | |
| SCHEMBL4273740 | 0.80 | TSHR (0.37) | TSHR | |
| SCHEMBL2376285 | 0.80 | DNM1 (0.38) | TSHR | |
| SCHEMBL4268923 | 0.79 | OPRM1 (0.42) | TSHR | |
| SCHEMBL4279290 | 0.79 | OPRM1 (0.42) | TSHR | |
| SCHEMBL4277187 | 0.79 | OPRM1 (0.42) | TSHR | |
| SCHEMBL4268932 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | claimed |
| CN-111479819-B | Method for preparing peptide and method for treating alkali | 中外制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| US-11976085-B2 | Process for producing ruthenium complexes and intermediates thereof and their use in olefin metathesis | Aperion Synthesis S.A. (PL) | 2024-05-07 | — | — | US | disclosed |
| WO-2024052871-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2024-03-14 | — | — | WO | disclosed |
| US-20240076308-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | APEIRON SYNTHESIS SA (PL) | 2024-03-07 | — | — | US | disclosed |
| WO-2023248205-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND THE USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2023-12-28 | — | — | WO | disclosed |
| EP-4196267-B1 | NOVEL RUTHENIUM COMPLEXES, METHODS OF THEIR PREPARATION AND APPLICATION THEREOF IN OLEFIN CROSS METATHESIS | APEIRON SYNTHESIS SA (PL) | 2023-11-29 | — | — | EP | disclosed |
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | APEIRON SYNTHESIS S.A. (PL) | 2023-10-12 | — | — | US | disclosed |
| US-20230295215-A1 | NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE | UNIWERSYTET WARSZAWSKI (PL) | 2023-09-21 | — | — | US | disclosed |
| CN-116724025-A | Process for producing azole derivative | 株式会社吴羽 | 2023-09-08 | — | — | CN | disclosed |
| CN-1112379-C | Propene polymer and preparation process thereof | MITSUI CHEMICALS INC (JP) | 2003-06-25 | — | — | CN | disclosed |
| CN-1112375-C | Olefin polymer catalyst and its use | MITSUI CHEMICALS INC (JP) | 2003-06-25 | — | — | CN | disclosed |
| CN-1049898-C | Olefin polymerization catalyst and method for preparing polypropylene and propylene block polymer | MITSUI CHEMICALS INC (JP) | 2000-03-01 | — | — | CN | disclosed |
| CN-1245813-A | Propylene block copolymer and its preparation method | MITSUI CHEMICALS INC (US) | 2000-03-01 | — | — | CN | disclosed |
| CN-1239105-A | Propene block copolymer and its preparing method | MITSUI CHEMICALS INC (JP) | 1999-12-22 | — | — | CN | disclosed |
| CN-1232829-A | Olefin polymer catalyst and its use | MITSUI CHEMICALS INC (JP) | 1999-10-27 | — | — | CN | disclosed |
| CN-1231294-A | Olefines polymerizing catalyst and use thereof | MITSUI CHEMICALS INC (JP) | 1999-10-13 | — | — | CN | disclosed |
| CN-1231293-A | Olefines polymerizing catalyst and use thereof | MITSUI CHEMICALS INC (JP) | 1999-10-13 | — | — | CN | disclosed |
| CN-1231295-A | Propene polymer and preparation process thereof | MITSUI CHEMICALS INC (JP) | 1999-10-13 | — | — | CN | disclosed |
| CN-1111643-A | Olefin polymerization catalyst and method for preparing polypropylene and propylene block polymer | MITSUI PETROCHEMICAL IND (JP) | 1995-11-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | CYP4F11, CYP4F3, CYP4F12 | TSHR 4763/4885TRPA1 3530/4885TRPV1 4041/4885 |
| US-11976085-B2 | Process for producing ruthenium complexes and intermediates thereof and their use in olefin metathesis | POR, CYP1B1, CYP4F11 | TSHR 4724/4885TRPA1 1891/4885TRPV1 3244/4885 |
| US-20240076308-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | POR, CYP1B1, CYP4F11 | TSHR 4724/4885TRPA1 1891/4885TRPV1 3244/4885 |
| US-20230295215-A1 | NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE | RNGTT, RNMT, NSUN3 | TSHR 3161/4885TRPA1 4734/4885TRPV1 4267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.